NYLIM
TVRD

New York Life Investment Management’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History

New York Life Investment Management’s Portfolio TVRD Stock Details TVRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,297
Closed -$501K – 1416
2022
Q4 		$501K Buy
1,297
+146
+13% +$56.4K 0.01% 931
2022
Q3 		$388K Buy
1,151
+85
+8% +$28.7K ﹤0.01% 969
2022
Q2 		$350K Buy
+1,066
New +$350K ﹤0.01% 1088